CLIC News Roundup – February 25
CLIC, in conjunction with NCATS, has developed a single stop for all your CTSA Program Meeting information. On the CTSA Program Meeting landing page within the CLIC website, you can find ALL information related Spring or Fall CTSA Program Meetings. You can also access materials for past and future CTSA Program Meetings, respond to NCATS polls to help select topics for upcoming meetings and send suggestions to the Steering Committee via the Suggestion Box.
If you have questions or need additional information, please contact the CLIC Event Planner at program_meetings@clic-ctsa.org.
News from around the CTSA Program Consortium
Washington University KL2 Scholar Utilizes CTSA Resources to Advance MRSA Research
Breakthrough research often requites years of training, time spent writing and countless hours coordinating resources. Such is the case for Stephanie Fritz, MD, MSCI, member of the Washington University Institute for Clinical and Translational Science (ICTS) and senior author of a new study on the superbug methicillin-resistant Staphylococcus aureus (MRSA). Recently published in The Lancet Infectious Diseases, the study investigates how MRSA is introduced into households and how it can spread among family members.
Fritz attributes much of her research success to the resources provided by the ICTS. Prior to Fritz’s work on this study, the ICTS helped to foster her success as a scholar with both the KL2 Career Development Awards Program and the Postdoctoral Mentored Training Program in Clinical Investigation (MTPCI).
Photo: Stephanie A. Fritz, MD, (left), with co-author Patrick Hogan. (Photo credit: Karen Elshout)
New Mayo Clinic Proceedings “The Compass” offers direction on bioethics issues in medicine
Mayo Clinic Proceedings recently added a new section, The Compass, which aims to promote discussion and analysis of bioethics issues and “questions of moral and clinical decision-making.” Some hot topics include artificial intelligence, burnout, financial conflicts and other emerging and under-examined issues.
“We’re attempting to fill an unmet need within the medical literature, where these ethical and humanistic issues can be discussed,” says Richard Sharp, Ph.D., who directs the Mayo Clinic Biomedical Ethics Research Program. “There are few journals that publish this type of content about emerging issues and under-examined topics, especially topics that have broad societal impacts or the potential to transform medicine.”
ICYMI: News from the Science & Research World
Harvard Gazette: Scientists from Harvard, China to unite against coronavirus
Harvard scientists are teaming up with researchers in China as part of a new five-year agreement to develop new diagnostics and therapies against the novel coronavirus that has continued to spread around the world. The $115 million deal will bring together basic scientists, translational investigators, and clinical researchers at Harvard Medical School, Harvard T.H. Chan School of Public Health, and Guangzhou Institute for Respiratory Health to study the new virus. The U.S. efforts are being led by Harvard biologist George Daley, and his counterpart in China is Zhong Nanshan, who is also heading the China National Health Commission’s task force set up to investigate the new virus.
